Molecular Formula | C10H16N2O6S3 |
Molar Mass | 356.44 |
Density | 1.575±0.06 g/cm3(Predicted) |
Melting Point | 112-115oC |
Boling Point | 612.4±65.0 °C(Predicted) |
Flash Point | 324.2°C |
Solubility | DMSO (Slightly), Methanol (Slightly) |
Vapor Presure | 7.49E-16mmHg at 25°C |
Appearance | Solid |
Color | White to Off-White |
pKa | 9.53±0.40(Predicted) |
Storage Condition | Sealed in dry,Room Temperature |
Refractive Index | 1.615 |
Application | (S)-3, 4-dihydro-4-hydroxy-2-(3-methoxypropyl)-2H-thieno [3,2-E]-1, 2-thiazin-6-sulfonamide 1, 1-dioxide is an intermediate of bulinzolamide. Brinzolamide [(4R) -4-(ethylamino) -3, 4-dihydro -2-(3-methoxypropyl)-2H-thieno [3,2-e] -1,2-thiazide -6-sulfonamido-1, 1-dioxide] is a carbonic anhydrase inhibitor that can be used to treat glaucoma. |